Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection - Wikidata - wikimedia - TriplyDB

Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection

Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection

http://www.wikidata.org/entity/Q35363127

about

HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2 Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from India HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities.HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination.Immunogenetics of small ruminant lentiviral infections Innate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls.Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage.Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages.Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus.The development of CD4 binding site antibodies during HIV-1 infection.The α7-nicotinic receptor is upregulated in immune cells from HIV-seropositive women: consequences to the cholinergic anti-inflammatory response Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion.Modeling the acute and chronic phases of Theiler murine encephalomyelitis virus infection.HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life.Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees Molecular basis for epitope recognition by non-neutralizing anti-gp41 antibody F240 Capacity for infectious HIV-1 virion capture differs by envelope antibody specificity.The Impact of Poxvirus Vector Priming, Protein Co-Administration, and Vaccine Intervals on HIV gp120 Vaccine-Elicited Antibody Magnitude and Function in Infant Macaques.Initiation of Antiretroviral Therapy During Acute HIV-1 Infection Leads to a High Rate of Nonreactive HIV Serology.Characteristics of Circulating Immune Complexes in HIV-Infected Patients with Different Viral Load.Mathematical model of multivalent virus-antibody complex formation in humans following acute and chronic HIV infections.Computational analysis of antibody dynamics identifies recent HIV-1 infection.A Bistable Switch in Virus Dynamics Can Explain the Differences in Disease Outcome Following SIV Infections in Rhesus Macaques.Correlation Between Anti-gp41 Antibodies and Virus Infectivity Decay During Primary HIV-1 Infection.Frequencies of Circulating Th1-Biased T Follicular Helper Cells in Acute HIV-1 Infection Correlate with the Development of HIV-Specific Antibody Responses and Lower Set Point Viral Load

P2860

Q27022055-A10C84CA-1A1E-4F59-8374-1C4DC0F4210C Q27318508-FBF41C97-085C-4A88-8053-445D83CD67C0 Q27468870-4F2B2FB6-860D-49C7-AD7A-5F7265D4DF94 Q27675879-3483E38F-05C0-4EDA-A805-39AE46A0CCCC Q28483205-1861A9A8-71F5-4D5C-BF35-93A91CF9CFF1 Q33900395-23D9D070-4336-464A-ABB9-F207CCCE0588 Q33939974-749C9131-772A-4AF0-A0D6-E67F683C38E4 Q33977866-80C80D02-B5AD-470D-946A-563FEA68F8FD Q34434913-BFA9B360-6E59-4C3E-ADEE-54689311D2A4 Q35085106-DE487DCC-57FD-4DFD-A028-05ADFBD5F889 Q35683986-109E87F0-A606-47C2-BE77-8039C70B205B Q35826158-38AFAF38-30F6-40C8-9EC1-70760C7CE5A5 Q35826784-C42AFC96-EA5D-4FCC-9878-2D53A2EC24B7 Q36155396-BB546DE0-1D7E-437D-BD22-573EA22AC91C Q36388273-3DD1B197-28FC-4207-8FC6-54CA681A4403 Q36559838-F8943A67-11B3-4966-9C69-6F596DBF314C Q36759689-8CD00B56-18A1-47E4-A6E5-58841F36E0B2 Q36874604-2C111C6E-18E3-40FA-8EF2-F78D529EA3AC Q36978671-7B5594E8-D6C4-484E-9C7C-4BBAEB8B5A45 Q37402557-48D4DD96-C677-4F25-8531-4E5D41081B53 Q37714023-CF2FEEF5-6B76-4EDC-A460-CBD39F2A9BB3 Q38621582-040849B7-27C5-4B92-B7C7-9B78AA0C8065 Q40693941-7720D9CE-A7AB-4A47-BA1C-BE7E1B074637 Q40990286-7D2DB07F-ACB9-4402-9926-945BED713E2D Q41752911-E492B19F-7994-4838-BCB7-8756D88B9BBC Q49762357-193197CF-4429-4011-A097-9C3A608766B5 Q55361754-44936288-65F7-4C2E-BB46-A931F78A5E10 Q55421347-A6C7BC8C-5FE3-47E6-872F-FDA4904A9DF1 Q57206379-5A23AA04-7281-4EE3-9B9D-B5A129FD2B71

P2860

Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection

http://www.wikidata.org/entity/Q35363127

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Dynamic antibody specificities ...... ute to chronic HIV-1 infection

@ast

Dynamic antibody specificities ...... ute to chronic HIV-1 infection

@en

type

label

Dynamic antibody specificities ...... ute to chronic HIV-1 infection

@ast

Dynamic antibody specificities ...... ute to chronic HIV-1 infection

@en

prefLabel

Dynamic antibody specificities ...... ute to chronic HIV-1 infection

@ast

Dynamic antibody specificities ...... ute to chronic HIV-1 infection

@en

P1433

Q35363127-8EC18AAC-A433-449C-9D5F-FDD0FC528F9E

P1476

Q35363127-83A393E0-46F7-4FDA-9DBC-D554A9058FA2

P2093

Q35363127-20624169-1EF1-41A4-AEDC-E50158767F2F

Q35363127-26FD043C-E43E-4090-96B5-B4BBC68F6CA9

Q35363127-3B6A137B-4EB1-4F3B-802F-6275E5C8C697

Q35363127-4D1BD76A-98EE-48F7-9BD1-2D7AF70AFB35

Q35363127-4D8525BE-C579-4B03-8E56-EA9EADA9223D

Q35363127-761670AE-E301-4CE9-9D5A-58E9DFC3EEDD

Q35363127-AC17B7D5-8758-4E54-8965-BCE87FBBE6E6

Q35363127-B48A1554-798E-4222-9583-0FB1D7A01EC3

Q35363127-B6AEE27C-A270-4E4A-B3B4-78F65ACE6C5B

Q35363127-E0A2B23F-D96A-46E8-85A4-27E973F2BC6A

P2860

Q35363127-069C3792-6894-4B30-AA6C-D823AF8B1105

Q35363127-0AD2524A-C72F-4DFF-B681-ABC7DB9B697A

Q35363127-23D8FDCC-D7CA-4689-BFC2-EDD3BE495B30

Q35363127-2547329D-90B8-4BD9-AF54-E7FE9B8E8E48

Q35363127-2B3CDC9F-CE0F-4AC3-8FA8-F4C0CD193C34

Q35363127-2DACA889-7490-4E4F-96D8-28BD511C8811

Q35363127-320E02C0-9F99-4533-9C4D-9EAE48B31834

Q35363127-3C7FA116-4824-444F-80B6-5814EED05BD1

Q35363127-3CAD1335-4E8A-4E6A-B62D-5354C53F6595

Q35363127-44C133DD-6BF7-44E0-96F1-B0C3E3C2BF37

P304

Q35363127-4937A3DC-B17B-4FF6-91B5-7D81CD73CCE8

P31

Q35363127-90504719-DAF2-4C3A-B2B5-5129BD0B24D0

P356

Q35363127-EEDD25B1-5FD1-4804-AA81-7E69B1865BA1

P407

Q35363127-7CA3DB04-F070-464E-BCC9-BC9FD906DDAE

P433

Q35363127-967C19E4-2285-410F-A564-DD646ED4AE4B

P478

Q35363127-CFFADF9B-6000-43FE-8E43-F66F913B9B81

P50

Q35363127-0DB1039C-759C-420C-B221-2D3C0FB12161

Q35363127-3F651132-3071-4F25-A410-FE2827F68EE5

Q35363127-70CA5744-F83F-4F3A-B4BD-191B1F0D9E82

Q35363127-E1139430-0533-4E16-A504-4B08E08A4837

P577

Q35363127-AC76DD2A-2D04-42B7-BE58-CC33C11838BD

P698

Q35363127-C5A83241-5013-4E68-8D3D-F6B5A858123C

P932

Q35363127-6E256A5C-5D86-49A3-A41D-F550140E27BB

P356

P1433

Journal of Virology

P1476

Dynamic antibody specificities ...... ute to chronic HIV-1 infection

@en

P2093

Christina Ochsenbauer

http://www.w3.org/2001/XMLSchema#string

Feng Gao

http://www.w3.org/2001/XMLSchema#string

Frederik Graw

http://www.w3.org/2001/XMLSchema#string

Georgia D Tomaras

http://www.w3.org/2001/XMLSchema#string

John C Kappes

http://www.w3.org/2001/XMLSchema#string

Nathan Vandergrift

http://www.w3.org/2001/XMLSchema#string

Nicole L Yates

http://www.w3.org/2001/XMLSchema#string

Pinghuang Liu

http://www.w3.org/2001/XMLSchema#string

R Glenn Overman

http://www.w3.org/2001/XMLSchema#string

S Munir Alam

http://www.w3.org/2001/XMLSchema#string

P2860

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

The neighbor-joining method: a new method for reconstructing phylogenetic trees

Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences

Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells

Human Immunodeficiency Virus Type 1 Subtype B Ancestral Envelope Protein Is Functional and Elicits Neutralizing Antibodies in Rabbits Similar to Those Elicited by a Circulating Subtype B Envelope

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

Distribution and three-dimensional structure of AIDS virus envelope spikes

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

Rapid dissociation of HIV-1 from cultured cells severely limits infectivity assays, causes the inactivation ascribed to entry inhibitors, and masks the inherently high level of infectivity of virions.

P304

11196-11207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.05601-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

Alan S. Perelson

David C Montefiori

P577

2011-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21865397

http://www.w3.org/2001/XMLSchema#string

P932

3194959

http://www.w3.org/2001/XMLSchema#string